References
- Awad E A. Phenol block for control of hip flexor and adductor spasticity. Arch Phys Med Rehabil 1972; 53: 554–557
- Greenbaum M G, Young M A, Frank J M. Attenuation of facial muscle spasticity with intramuscular phenol neurolysis. Arch Phys Med Rehabil 1993; 74: 217–219
- Hecht J S. Subscapular nerve block in the painful hemiplegic shoulder. Arch Phys Med Rehabil 1992; 73: 1036–1039
- Cameron-Strange A, Millard R J. Management of refractory detrusor instability by transvesical phenol injection. Br J Urol 1988; 62: 323–325
- Petrillo C R, Knoploch S. Phenol block of the tibial nerve for spasticity: a long-term follow-up study. Int Disabil Stud 1988; 10: 97–100
- Chironna R L, Hecht J S. Subscapularis motor point block for the painful hemiplegic shoulder. Arch Phys Med Rehabil 1990; 71: 428–429
- Coffey R J, Cahill D, Steers W, Park T S, Ordia J, Meythaler J, Herman R, Shetter A G, Levy R, Gill B, Smith R, Wilberger J, Loeser J D, Chabal C, Feler C, Robertson J T, Penn R D, Clarke A, Burchiel K J, Leibrock L G. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 1993; 78: 226–232
- www.southshoreneurologic.com (accessed 16/11/06)
- Maher R M. Relief of pain in incurable cancer. Lancet 1955; 1: 18–20
- Nathan P W. Intrathecal phenol to relieve spasticity in paraplegia. Lancet 1959; 2: 1099–1102
- Kelly R E, Gautier-Smith P C. Intrathecal phenol in the treatment of reflex spasms and spasticity. Lancet 1959; 2: 1102–1105
- Liversedge L A, Maher R M. Use of phenol in relief of spasticity. BMJ 1960; 2: 31–33
- Koppang K. Intrathecal phenol in the treatment of spastic conditions. Acta Neurol Scand Suppl 1962; 38: 63–68
- Pederson E, Juul-Jensen P. Intrathecal phenol in the treatment of spasticity. Acta Neurol Scand Suppl 1962; 38: 69–77
- Pederson E, Juul-Jensen P. Treatment of spasticity by subarachnoid phenoglycerin. Neurology 1965; 15: 256–262
- Jarrett L, Nandi P, Thompson A J. Managing severe lower limb spasticity in multiple sclerosis: does intrathecal phenol have a role?. J Neurol Neurosurg Psychiatr 2002; 73: 705–709
- Iwatsubo E, Okada E, Takehara T, Tamada K, Akatsu T. Selective intrathecal phenol block to improve activities of daily living in patients with spastic quadriplegia. A preliminary report. Paraplegia 1994; 32: 489–492
- Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964; 192: 540–542
- Pedersen E, Reske-Nielsen E. Neuropathology of subarachnoid phenol-glycerin. Acta Neuropathol (Berl) 1965; 5: 112–116
- Hansebout R R, Cosgrove J B. Effects of intrathecal phenol in man. A histological study. Neurology 1966; 16: 277–282